Multicenter, Prospective, randomized, comparative and controlled study about the beneficial effects in behavior and brain connectivity of different dietary patterns in 100 children with ADHD between 7 and 12 years, followed up for 3 months of nutritional therapy.

the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements

Dietary Supplement: Low carbohydrate diet

the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements

Other Name: 2000 Kilo-calories without Fast Absorbing Carbohydrate

Detailed Description:

The investigators collect electroencephalogram (EEG), event related potentials (ERP) data, and behavior parameters in ADD/ADHD children that not take stimulants or other drugs during study. They would only follow some nutritional recommendations based on increasing the amount of dietary protein and fast carbohydrates decrease. The duration of the study will be 6 months, 3 months for recruitment and 3 months for dietary treatment.

Eligibility

Ages Eligible for Study:

7 Years to 13 Years

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

ADHD diagnosed 12 months before

no take medication

BMI above the 25th percentile

Wiesel score between 80 and 100 (about 120)

Patients who agree to participate and whose guardians signed the informed consent form

Exclusion Criteria:

eating disorders

psychosis, bipolar disorder or depression

kidney or liver failure

diabetes

diuretic or cortisone treatment

haematological problems

suprarenal diseases

cancer

Brain injury

Cardiovascular or arrhythmia problems

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01856686